SAGE launches interactive, adaptive courseware for research methods
Los Angeles, CA - SAGE today announces the launch of Translational Epigenomics, a new open access journal publishing research on epigenetic alterations in gene expression.
Translational Epigenomics will cover diverse aspects of this new and emergent field such as DNA methylation, posttranslational histone modifications, and non-mutational RNA regulatory mechanisms. The journal welcomes basic science and clinical medical specialty submissions.
Dr. Gaurang S. Daftary, the journal’s Editor-In-Chief commented on the development of this field of study:
“Epigenetics, one of the fastest-growing scientific disciplines, investigates how each cell works ‘around’ its genomic blueprint to adapt and thrive in equilibrium with its unique internal and external environment. With its emphasis on biological function, epigenetic research rapidly lends itself to translational interpretation to human health and disease. Translational Epigenomics is an evolved home for research and processes that will transform human health and medicine in our up-and-coming ‘epigenomic era.’”
Now open for submissions, Translational Epigenomics will focus on translational applicability and relevance of the research findings to health and disease.
“SAGE is proud to be among the first to publish an open access journal in epigenomics, continuing our rich history of publishing in new and emerging fields of study. We are confident that Translational Epigenomics’ high quality research will be widely applicable in practice for the treatment of disease and the improvement of human health,” commented Bob Howard, Vice President of Journals at SAGE.
To learn more, visit link.
Contact (media inquiries only)
- Camille Gamboa, Director of Corporate Communications and Public Affairs: email@example.com / Tel: (+1) 805-410-7441